Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In a new blog series, researchers in the OxImmnuo Literature initiative select papers that cover topics in COVID-19 research that they think may be of interest to the wider public and summarise them for a more general audience

Stack of academic papers with text highlighted and a pen resting on top

The OxImmuno Literature initiative has collected together a team of around 100 researchers from the Medical Sciences Division of the University of Oxford to read, review and summarise recent COVID-19 research from all round the world in order to support the researchers working on COVID-19 here at the University of Oxford.

Research papers are peer reviewed, ie. read and checked by other scientists, before they are published in research journals. As COVID-19 is such a new phenomenon most of the research has not yet had time to be peer reviewed but, in order to help other scientists working on COVID-19, research is still made available as a pre-print for other researchers to read.

Our summaries of some of these pre-prints and papers can be read here. However, these are written for other researchers. We have selected a few papers that cover topics in COVID-19 research that we think may be of interest to the wider public and have summarised them for a more general audience and included more background information. These summaries, with links to the original research, can be found in this, our new blog.

The blogs are available on the Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences website

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.